Pilocarpine

Pilocarpine is a naturally occurring alkaloid that acts as a muscarinic, or parasympathomimetic, agent, meaning it reproduces the effects of the parasympathetic nervous system ^[2]. It is extracted from the leaves of Pilocarpus plants, particularly the Maranham jaborandi of northern Brazil, and it was first isolated in the nineteenth century; it is included on the World Health Organization's List of Essential Medicines.

Its oldest and most familiar uses are in the eye. As a miotic, a drug that constricts the pupil, pilocarpine lowers the pressure inside the eye and has long been used to treat glaucoma and ocular hypertension, and it is also used to reverse pupil dilation. More recently, a low-dose eye drop formulation was approved in 2021 for presbyopia, the gradual loss of near focusing that comes with age; phase 3 trials showed that it improved near vision without seriously compromising distance vision ^[2]. Because the same pupil-narrowing effect can dim vision in low light, studies have specifically examined its impact on night driving ^[3]. Ophthalmic pilocarpine is sold under names such as Isopto Carpine and, for presbyopia, Vuity.

Taken by mouth as tablets, marketed as Salagen, pilocarpine is used to treat dry mouth, or xerostomia. Randomized controlled trials found that it significantly increased salivary flow and relieved symptoms of dryness in patients with Sjögren syndrome, an autoimmune disorder that damages the moisture-producing glands, and it is likewise used for dry mouth following radiation therapy to the head and neck ^[1][4]. A separate application takes advantage of its ability to stimulate sweat glands: pilocarpine is used in the sweat test that helps diagnose cystic fibrosis.

Pilocarpine is a prescription medicine available as eye drops and gels and as oral tablets ^[2]. Its effects flow directly from its action on the exocrine glands and smooth muscle of the eye, and its side effects likewise reflect this widespread parasympathetic stimulation ^[1].

Pilocarpine is prescription only. Eye drops commonly cause brow ache, dim or blurred vision especially in low light, a shift toward nearsightedness, and stinging on instillation; there is a small risk of retinal detachment, so sudden flashes or floaters need urgent review. Taken by mouth, the most common effect is sweating, along with flushing, runny nose, urinary urgency, nausea, and sometimes a slow heartbeat. Because it stimulates the parasympathetic system broadly, it should be avoided or used carefully in uncontrolled asthma or COPD, where it can trigger bronchospasm, and in acute iritis or certain narrow-angle situations. Caution also applies in significant heart disease, peptic ulcer, and gallbladder or urinary tract obstruction.

Pilocarpine is a non-selective muscarinic agonist, so its interactions are mostly pharmacodynamic rather than metabolic. Beta blockers are the pairing that carries real cardiac risk: both slow conduction, and the combination has been linked to bradycardia and atrioventricular block. The same logic applies in the airway, where a cholinergic agonist and a non-selective beta blocker both push toward bronchoconstriction in people with asthma or COPD.

Drugs with anticholinergic activity work directly against pilocarpine. Atropine, oxybutynin, tricyclic antidepressants and sedating antihistamines blunt the secretory effect pilocarpine is given for, and pilocarpine in turn erodes their intended antimuscarinic action. Pointed the other way, adding it to another cholinergic agent such as bethanechol, or to a cholinesterase inhibitor like donepezil or pyridostigmine, stacks muscarinic excess: sweating, nausea, cramping, urinary urgency and a slow pulse.

Pilocarpine is cleared by plasma esterases and CYP2A6 and inhibits CYP2A6 as well, but that enzyme handles few drugs and the interaction carries little clinical weight.

Checking a whole stack? Run it through interactions + stacks.

Pilocarpine is a plant alkaloid extracted from the leaves of Pilocarpus shrubs, known as jaborandi, which are native to Brazil and had long been used by Indigenous peoples for their ability to provoke sweating and salivation. The active alkaloid was isolated in 1875, credited independently to the English chemist Alfred Gerrard and to the physician Edward Hardy, and its powerful effect on the eye was recognized almost immediately. By the closing decades of the nineteenth century pilocarpine had become a foundational treatment for glaucoma, lowering pressure inside the eye by opening its drainage pathways, a role it retained for more than a century.

In 1994 an oral tablet formulation, marketed as Salagen, was approved to relieve the dry mouth caused by Sjogren syndrome and by radiation therapy to the head and neck. Most recently, in 2021 the Food and Drug Administration approved a low-dose 1.25 percent eye drop, developed by Allergan as AGN-190584 and sold as Vuity, for the age-related loss of near vision known as presbyopia, giving this venerable botanical drug a striking modern revival.

Pilocarpine is a remarkably enduring medicine, a nineteenth-century botanical alkaloid that has continually found new purpose across more than a hundred and forty years of practice. For glaucoma it was long a dependable pressure-lowering agent, and as an oral tablet it provides real relief to patients whose salivary glands have been damaged by Sjogren syndrome or radiation, restoring comfort that few other drugs can offer.

Its most attention-grabbing recent chapter is in presbyopia, where a low-dose drop harnesses the pupil-narrowing pinhole effect to sharpen near vision in a phase 3 program that met its primary endpoints, offering some people an alternative to reading glasses. Candor requires noting its cholinergic side effects; the same activity that helps can cause brow ache, dim vision in low light, and increased sweating, and a rare risk of retinal detachment prompts caution in susceptible eyes. That such an old molecule continues to earn new approvals is testament to its genuine and well-characterized usefulness.